These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 10928576)
1. The use of dopamine agonists in very elderly patients with Parkinson's disease. Shulman LM; Minagar A; Rabinstein A; Weiner WJ Mov Disord; 2000 Jul; 15(4):664-8. PubMed ID: 10928576 [TBL] [Abstract][Full Text] [Related]
2. [The role of dopaminagonists in the treatment of Parkinson's disease]. Ransmayr G Praxis (Bern 1994); 2005 Oct; 94(42):1633-8. PubMed ID: 16277084 [TBL] [Abstract][Full Text] [Related]
3. Conversion from dopamine agonists to cabergoline: an open-label trial in 128 patients with advanced Parkinson disease. Linazasoro G; Clin Neuropharmacol; 2008; 31(1):19-24. PubMed ID: 18303487 [TBL] [Abstract][Full Text] [Related]
4. Conversion from dopamine agonists to pramipexole. An open-label trial in 227 patients with advanced Parkinson's disease. Linazasoro G; J Neurol; 2004 Mar; 251(3):335-9. PubMed ID: 15015015 [TBL] [Abstract][Full Text] [Related]
5. Pergolide and Parkinson's disease: new preparation. No clear benefit. Prescrire Int; 2000 Dec; 9(50):177-9. PubMed ID: 11475497 [TBL] [Abstract][Full Text] [Related]
6. Burden of cardiovascular diseases in elderly with Parkinson's disease who start a dopamine agonist agent. Trifirò G; Morgante L; Tari M; Arcoraci V; Savica R J Am Geriatr Soc; 2008 Feb; 56(2):371-3. PubMed ID: 18251828 [No Abstract] [Full Text] [Related]
9. Ropinirole and pramipexole, the new agonists. Hobson DE; Pourcher E; Martin WR Can J Neurol Sci; 1999 Aug; 26 Suppl 2():S27-33. PubMed ID: 10451757 [TBL] [Abstract][Full Text] [Related]
10. Pergolide in the treatment of patients with early and advanced Parkinson's disease. Bonuccelli U; Colzi A; Del Dotto P Clin Neuropharmacol; 2002; 25(1):1-10. PubMed ID: 11852289 [TBL] [Abstract][Full Text] [Related]
11. Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease. Navan P; Findley LJ; Jeffs JA; Pearce RK; Bain PG Mov Disord; 2003 Feb; 18(2):176-80. PubMed ID: 12539211 [TBL] [Abstract][Full Text] [Related]
12. [Dopaminergic agonists in the treatment of Parkinson's disease]. Supiot F; Sternon J; Zegers de Beyl D Rev Med Brux; 2000 Dec; 21(6):493-9. PubMed ID: 11194495 [TBL] [Abstract][Full Text] [Related]